Michele Minopoli

1.9k total citations · 2 hit papers
22 papers, 1.3k citations indexed

About

Michele Minopoli is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michele Minopoli has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Michele Minopoli's work include Protease and Inhibitor Mechanisms (7 papers), Cell Adhesion Molecules Research (7 papers) and S100 Proteins and Annexins (6 papers). Michele Minopoli is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Cell Adhesion Molecules Research (7 papers) and S100 Proteins and Annexins (6 papers). Michele Minopoli collaborates with scholars based in Italy, Sri Lanka and Germany. Michele Minopoli's co-authors include Maria Vincenza Carriero, Maria Teresa Masucci, Silvana Del Vecchio, Maria Letizia Motti, Vincenzo Ingangi, Concetta Ragone, Katia Bifulco, Paolo A. Ascierto, Gerardo Botti and Ali Munaim Yousif and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Michele Minopoli

22 papers receiving 1.3k citations

Hit Papers

Tumor Associated Neutroph... 2019 2026 2021 2023 2019 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
    2019 480 citations Maria Teresa Masucci, Michele Minopoli et al. Frontiers in Oncology profile →
  2. The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis
    2020 368 citations Maria Teresa Masucci, Michele Minopoli et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Minopoli Italy 17 625 479 478 261 163 22 1.3k
Boxuan Zhou China 14 717 1.1× 521 1.1× 438 0.9× 299 1.1× 173 1.1× 40 1.4k
Elisabeth J. M. Huijbers Netherlands 19 432 0.7× 697 1.5× 486 1.0× 347 1.3× 146 0.9× 35 1.3k
Veronica C. Ardi United States 14 539 0.9× 596 1.2× 542 1.1× 336 1.3× 110 0.7× 15 1.4k
Crescenzo D’Alterio Italy 19 533 0.9× 371 0.8× 849 1.8× 186 0.7× 172 1.1× 36 1.3k
Justin M. David United States 18 558 0.9× 543 1.1× 769 1.6× 211 0.8× 218 1.3× 30 1.4k
Xiaoqian Zhang China 6 824 1.3× 874 1.8× 411 0.9× 636 2.4× 138 0.8× 12 1.7k
Yael Raz Israel 12 451 0.7× 614 1.3× 682 1.4× 263 1.0× 126 0.8× 17 1.2k
Terufumi Kubo Japan 20 437 0.7× 477 1.0× 504 1.1× 153 0.6× 243 1.5× 92 1.3k
Kenneth C. Valkenburg United States 7 313 0.5× 446 0.9× 526 1.1× 233 0.9× 148 0.9× 8 1.1k
Haoting Sun China 13 364 0.6× 713 1.5× 244 0.5× 447 1.7× 137 0.8× 26 1.2k

Countries citing papers authored by Michele Minopoli

Since Specialization
Citations

This map shows the geographic impact of Michele Minopoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Minopoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Minopoli more than expected).

Fields of papers citing papers by Michele Minopoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Minopoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Minopoli. The network helps show where Michele Minopoli may publish in the future.

Co-authorship network of co-authors of Michele Minopoli

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Minopoli. A scholar is included among the top collaborators of Michele Minopoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Minopoli. Michele Minopoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ingangi, Vincenzo, Annarosaria De Chiara, Michele Gallo, et al.. (2024). Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma. Cells. 13(11). 977–977. 7 indexed citations
2.
Masucci, Maria Teresa, et al.. (2023). Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors. International Journal of Molecular Sciences. 24(7). 6026–6026. 10 indexed citations
3.
Cusano, Angela Maria, Paola Cicatiello, Giorgia Celetti, et al.. (2023). Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells. International Journal of Nanomedicine. Volume 18. 4121–4142. 22 indexed citations
4.
Minopoli, Michele, Francesca Di Modugno, Andrea Sacconi, et al.. (2023). Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin. Journal of Experimental & Clinical Cancer Research. 42(1). 317–317. 8 indexed citations
5.
Masucci, Maria Teresa, et al.. (2022). Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer. Cancers. 14(3). 498–498. 34 indexed citations
6.
Minopoli, Michele, et al.. (2022). p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors. Cancers. 15(1). 121–121. 4 indexed citations
7.
Roca, Maria Serena, Tania Moccia, Federica Iannelli, et al.. (2022). HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation. Journal of Experimental & Clinical Cancer Research. 41(1). 83–83. 36 indexed citations
8.
Minopoli, Michele, Rosa Azzaro, Susan Costantini, et al.. (2020). Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma. Cells. 9(4). 1062–1062. 16 indexed citations
9.
Motti, Maria Letizia, et al.. (2020). MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. 21(12). 4544–4544. 27 indexed citations
10.
Mosca, Laura, Michele Minopoli, Martina Pagano, et al.. (2020). Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms. International Journal of Oncology. 56(5). 1212–1224. 27 indexed citations
11.
Masucci, Maria Teresa, Michele Minopoli, Silvana Del Vecchio, & Maria Vincenza Carriero. (2020). The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis. Frontiers in Immunology. 11. 1749–1749. 368 indexed citations breakdown →
12.
Ingangi, Vincenzo, Michele Minopoli, Concetta Ragone, Maria Letizia Motti, & Maria Vincenza Carriero. (2019). Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells. Frontiers in Oncology. 9. 82–82. 53 indexed citations
13.
Minopoli, Michele, Gerardo Botti, Vincenzo Gigantino, et al.. (2019). Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion. Journal of Experimental & Clinical Cancer Research. 38(1). 459–459. 16 indexed citations
14.
Masucci, Maria Teresa, Michele Minopoli, & Maria Vincenza Carriero. (2019). Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy. Frontiers in Oncology. 9. 1146–1146. 480 indexed citations breakdown →
15.
Camerlingo, Rosa, Maria Vincenza Carriero, Giuseppe Pirozzi, et al.. (2018). Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells. International Journal of Oncology. 53(3). 1149–1159. 20 indexed citations
16.
Ragone, Concetta, Michele Minopoli, Vincenzo Ingangi, et al.. (2017). Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells. Journal of Experimental & Clinical Cancer Research. 36(1). 180–180. 16 indexed citations
17.
Yousif, Ali Munaim, Vincenzo Ingangi, Francesco Merlino, et al.. (2017). Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration. European Journal of Medicinal Chemistry. 143. 348–360. 21 indexed citations
18.
Carriero, Maria Vincenza, Katia Bifulco, Vincenzo Ingangi, et al.. (2017). Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas. Scientific Reports. 7(1). 1312–1312. 24 indexed citations
19.
Yousif, Ali Munaim, Michele Minopoli, Katia Bifulco, et al.. (2015). Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes. PLoS ONE. 10(5). e0126172–e0126172. 25 indexed citations
20.
Carriero, Maria Vincenza, Katia Bifulco, Michele Minopoli, et al.. (2014). UPARANT: A Urokinase Receptor–Derived Peptide Inhibitor of VEGF-Driven Angiogenesis with Enhanced Stability and In Vitro and In Vivo Potency. Molecular Cancer Therapeutics. 13(5). 1092–1104. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boxuan Zhou Breakdown of academic impact, for papers by Elisabeth J. M. Huijbers Breakdown of academic impact, for papers by Veronica C. Ardi Breakdown of academic impact, for papers by Crescenzo D’Alterio Breakdown of academic impact, for papers by Justin M. David Breakdown of academic impact, for papers by Xiaoqian Zhang Breakdown of academic impact, for papers by Yael Raz Breakdown of academic impact, for papers by Terufumi Kubo Breakdown of academic impact, for papers by Kenneth C. Valkenburg Breakdown of academic impact, for papers by Haoting Sun
Rankless by CCL
2026